Vik Chopra Analyst PerformanceMedTech Equity Research Analyst at Wells Fargo & CompanyVik Chopra is a stock analyst at Wells Fargo & Company in the medical sector, covering 11 publicly traded companies. Over the past year, Vik Chopra has issued 17 stock ratings, including buy and hold recommendations. While full access to Vik Chopra's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Vik Chopra's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings17 Last 0 YearsBuy Recommendations47.06% 8 Buy RatingsCompanies Covered11 Unique Companies Ratings Distribution17RatingsDistribution of strong buy, buy, hold, and sell ratings by Vik Chopra.RatingPercentageCount Strong Buy0.0%0 ratings Buy47.1%8 ratings Hold52.9%9 ratings Sell0.0%0 ratingsOut of 17 total stock ratings issued by Vik Chopra at Wells Fargo & Company, the majority (52.9%) have been Hold recommendations, followed by 47.1% Buy.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ54.5% of companies on NASDAQ6 companiesNYSE45.5% of companies on NYSE5 companiesVik Chopra, an analyst at Wells Fargo & Company, currently covers 11 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical11 companies100.0%Vik Chopra of Wells Fargo & Company specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS4 companies36.4%MED/DENTAL - SUPP4 companies36.4%MEDICAL INFO SYS1 company9.1%MEDICAL SERVICES1 company9.1%MED PRODUCTS1 company9.1% Vik Chopra's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNPCENeuroPace8/13/2025Lower Price Target$9.13$15.00Overweight$0.0000.00% ROIGMEDGlobus Medical8/8/2025Lower Price Target$56.92$66.00Overweight$0.0000.00% ROIENOVEnovis8/8/2025Lower Price Target$28.26$41.00Overweight$0.0000.00% ROISOLVSolventum8/8/2025Boost Price Target$73.26$79.00Equal Weight$0.0000.00% ROIXRAYDENTSPLY SIRONA8/8/2025Lower Price Target$12.79$15.00Equal Weight$0.0000.00% ROINVSTEnvista8/1/2025Boost Price Target$20.53$19.00Equal Weight$0.0000.00% ROIALGNAlign Technology7/31/2025Lower Price Target$132.69$199.00Overweight$0.0000.00% ROIMASIMasimo5/7/2025Lower Price Target$149.23$190.00Overweight$0.0000.00% ROIIARTIntegra LifeSciences5/6/2025Lower Price Target$13.27$13.00Equal Weight$0.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$56.93$57.00Equal Weight$0.0000.00% ROISOLVSolventum2/28/2025Boost Price Target$79.28$75.00Equal Weight$0.0000.00% ROIMASIMasimo2/26/2025Boost Price Target$169.54$205.00Overweight$0.0000.00% ROIGMEDGlobus Medical2/21/2025Lower Price Target$82.74$93.00Overweight$0.0000.00% ROIALGNAlign Technology2/14/2025Initiated Coverage$204.89$255.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA2/14/2025Initiated Coverage$18.77$20.00Equal Weight$0.0000.00% ROIHSICHenry Schein2/14/2025Initiated Coverage$77.62$80.00Equal Weight$0.0000.00% ROICNMDCONMED2/6/2025Lower Price Target$70.96$70.00Equal Weight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
